Correlation Between Larimar Therapeutics and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and MAIA Biotechnology, you can compare the effects of market volatilities on Larimar Therapeutics and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and MAIA Biotechnology.
Diversification Opportunities for Larimar Therapeutics and MAIA Biotechnology
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Larimar and MAIA is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and MAIA Biotechnology
Given the investment horizon of 90 days Larimar Therapeutics is expected to under-perform the MAIA Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Larimar Therapeutics is 1.0 times less risky than MAIA Biotechnology. The stock trades about -0.22 of its potential returns per unit of risk. The MAIA Biotechnology is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 251.00 in MAIA Biotechnology on October 25, 2024 and sell it today you would lose (56.00) from holding MAIA Biotechnology or give up 22.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. MAIA Biotechnology
Performance |
| Timeline |
| Larimar Therapeutics |
| MAIA Biotechnology |
Larimar Therapeutics and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and MAIA Biotechnology
The main advantage of trading using opposite Larimar Therapeutics and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |